- Home
- ELDN vs CXDO Comparison
ELDN vs CXDO Comparison
Compare ELDN & CXDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- CXDO
- Stock Information
- Founded
- ELDN 2004
- CXDO 1995
- Country
- ELDN United States
- CXDO United States
- Employees
- ELDN N/A
- CXDO N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- CXDO Telecommunications Equipment
- Sector
- ELDN Health Care
- CXDO Telecommunications
- Exchange
- ELDN Nasdaq
- CXDO Nasdaq
- Market Cap
- ELDN 140.3M
- CXDO 134.4M
- IPO Year
- ELDN N/A
- CXDO 1998
- Fundamental
- Price
- ELDN $4.07
- CXDO $5.03
- Analyst Decision
- ELDN Strong Buy
- CXDO Strong Buy
- Analyst Count
- ELDN 1
- CXDO 2
- Target Price
- ELDN $16.00
- CXDO $6.50
- AVG Volume (30 Days)
- ELDN 1.0M
- CXDO 165.5K
- Earning Date
- ELDN 11-12-2024
- CXDO 11-06-2024
- Dividend Yield
- ELDN N/A
- CXDO N/A
- EPS Growth
- ELDN N/A
- CXDO N/A
- EPS
- ELDN N/A
- CXDO 0.05
- Revenue
- ELDN N/A
- CXDO $58,762,000.00
- Revenue This Year
- ELDN N/A
- CXDO $15.54
- Revenue Next Year
- ELDN N/A
- CXDO $10.50
- P/E Ratio
- ELDN N/A
- CXDO $108.94
- Revenue Growth
- ELDN N/A
- CXDO 16.41
- 52 Week Low
- ELDN $1.11
- CXDO $2.59
- 52 Week High
- ELDN $5.54
- CXDO $7.59
- Technical
- Relative Strength Index (RSI)
- ELDN 51.95
- CXDO 43.30
- Support Level
- ELDN $3.76
- CXDO $4.78
- Resistance Level
- ELDN $4.17
- CXDO $5.37
- Average True Range (ATR)
- ELDN 0.39
- CXDO 0.35
- MACD
- ELDN -0.15
- CXDO -0.08
- Stochastic Oscillator
- ELDN 18.45
- CXDO 18.94
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About CXDO Crexendo Inc.
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of revenue from the Cloud telecommunications segment.